Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Tamibarotene Compared to All-Trans Retinoic Acid (ATRA) As Add-on to Arsenic Trioxide (ATO) in Subjects with Relapsed Acute Promyelocytic Leukemia (APL)

Jianxiang Wang, MD PhD, Yingchang Mi, MD PhD, Bin Jiang, Xiequn Chen, Chunyan Ji, MD PhD, Yan Li, Xielan Zhao, Yongrong Lai, Yu Hu, MD, PhD, Aiping Tang, Ting Liu, MDPhD, Jie Jin, MD PhD, Junmin Li, Linhua Yang, Jianyong Li, MD PhD, Fanyi Meng

Blood (2015) 126 (23): 220.

https://doi.org/10.1182/blood.V126.23.220.220

Published: 2015

Journal Articles

Palladin Plays an Important Role in Pulmonary Cellular Infiltration in Differentiation Syndrome

Haimin Sun, Xinlei Chen, Xin Xu, Sai-juan Chen

Blood (2014) 124 (21): 4947.

https://doi.org/10.1182/blood.V124.21.4947.4947

Published: 2014

Journal Articles

How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia

Miguel A. Sanz, Pau Montesinos

Blood (2014) 123 (18): 2777–2782.

https://doi.org/10.1182/blood-2013-10-512640

Published: 2014

Journal Articles

Successful Pregnancy In APL Patients Treated According to the AIDA Protocol.

Paola Carluccio, Alessandra Ricco, Domenico Pastore, Massimo Breccia, MD, Maria Grazia Kropp, Eros Di Bona, Francesco Fabbiano, Felicetto Ferrara, MD, Lorella Melillo, Francesco Lo-Coco, MD, Giorgina Specchia

Blood (2010) 116 (21): 1037.

https://doi.org/10.1182/blood.V116.21.1037.1037

Published: 2010

Journal Articles

Chemokine Induction by All-Trans Retinoic Acid in Acute Promyelocytic Leukemia - Triggering the Retinoic Acid Syndrome

Maaike Luesink, MD, Jeroen Pennings, PhD, Willemijn Wissink, Msc, Peter Linssen, Petra Muus, MD, PhD, Rolf Pfundt, PhD, Richard Huijbens, Theo de Witte, MD, PhD, Bert van der Reijden, PhD, Joop H. Jansen, PhD

Blood (2008) 112 (11): 2980.

https://doi.org/10.1182/blood.V112.11.2980.2980

Published: 2008

Journal Articles

The Clinical Features and the Efficient Therapy of 66 Acute Promyelocytic Leukemia Patients with High Initial White Blood Cell Count.

Hui-ying Qiu, MD, PhD, Meng-xing Xue, PhD, Ai-ning Sun, MD, PhD, Yue-jun Liu, MD, PhD, De Pei Wu, MD, PhD

Blood (2007) 110 (11): 4363.

https://doi.org/10.1182/blood.V110.11.4363.4363

Published: 2007

Journal Articles

Risk-Adapted Treatment of Acute Promyelocytic Leukemia: Updated Results of the Spanish PETHEMA LPA99 Trial Using ATRA and Anthracycline Monochemotherapy.

Miguel A. Sanz, PhD, Pau Montesinos, MD, Edo Vellenga, PhD, Chelo Rayon, PhD, Ricardo Parody, PhD, Javier de la Serna, PhD, Juan Bergua, PhD, Angel Leon, PhD, Silvia Negri, PhD, Concha Rivas, PhD, Salut Brunet, PhD, Marcos Gonzalez, PhD, Jordi Esteve, PhD, Bob Lowenberg, PhD

Blood (2007) 110 (11): 590.

https://doi.org/10.1182/blood.V110.11.590.590

Published: 2007

Journal Articles

A Phase I Trial of Bexarotene, a Retinoid X Receptor Agonist, in non-M3 Acute Myeloid Leukemia: Evidence of Myeloid Differentiation and Clinical Activity.

Donald E. Tsai, MD, PhD, Selina Luger, MD, Allison Kemner, RN, Alison W. Loren, MD, Cezary Swider, PhD, Ami Goradia, MD, Charalambos Andreadis, MD, Richard G. Ghalie, MD, James Thompson, MD, David Porter, MD, Edward A. Stadtmauer, MD, Stephen J. Schuster, MD, Alexander Perl, MD, Adam Bagg, MD, Steven Goldstein, MD, Martin Carroll, MD

Blood (2006) 108 (11): 1955.

https://doi.org/10.1182/blood.V108.11.1955.1955

Published: 2006

Journal Articles

A Novel and Efficient Induction Approach for Accelerated Differentiation and Rapid Hematopoietic Recovery in Acute Promyelocytic Leukemia (APL) Patients by Combining All-Trans Retinoic Acid (ATRA) with Granulocyte-Colony Stimulating Factor (G-CSF).

Shripad D. Banavali, MD, Lovenish Goyal, MD, Reena Nair, MD, Prasad Narayan, MD, Brijesh Arora, MD, Pratibha Amre-Kadam, PhD, Chanda Baisane, Bsc, Shashikant Mahadik, Msc, Sumit Gujral, MD, Purna A. Kurkure, MD, Purvish M. Parikh, MD

Blood (2006) 108 (11): 4566.

https://doi.org/10.1182/blood.V108.11.4566.4566

Published: 2006

Journal Articles

Increased Expression of Cyclin A1 mRNA Is a Novel Adverse Prognostic Indicator for Acute Promyelocytic Leukemia in Differentiation Therapy by All- Trans Retinoic Acid.

Tsuyoshi Nakamaki, MD, Hidetoshi Nakashima, MD, Masamichi Hattori, MD, Takako Usui, MD, Mayumi Honma, MD, Daisuke Adachi, MD, Bungo Saito, MD, Shigeru Tomoyasu, MD

Blood (2006) 108 (11): 2344.

https://doi.org/10.1182/blood.V108.11.2344.2344

Published: 2006

Journal Articles

Retinoic Acid Syndrome in Patients with Acute Promyelocytic Leukemia Treated with All-Trans Retinoic Acid and Anthracycline Monochemotherapy.

Pau Montesinos, MD, Juan Bergua, PhD, Guillermo Martin, PhD, Javier de la Serna, PhD, Edo Vellenga, PhD, Consuelo Rayon, PhD, Ricardo Parody, PhD, Jordi Esteve, PhD, Marcos Gonzalez, PhD, Jose Gonzalez, PhD, Miguel Sanz, PhD

Blood (2006) 108 (11): 2010.

https://doi.org/10.1182/blood.V108.11.2010.2010

Published: 2006

Journal Articles

Implications of RA-Induced CD38 Antigne in IFN gamma and IL-1 beta Induced Apoptosis of Endothelial Cells and Development of Retinoic Acid Syndrome.

Yin Gao, PhD, Kapil Mehta, PhD

Blood (2005) 106 (11): 2217.

https://doi.org/10.1182/blood.V106.11.2217.2217

Published: 2005

Journal Articles

Curcumin Enhances Differentiation of All- Trans Retinoic Acid (ATRA)-Sensitive and ATRA-Resistant Acute Promyelocytic (APL) Cells.

Ameet R. Kini, MD, PhD, Moolky Nagabhushan, PhD, Martin S. Tallman, MD, Shantanu Roychowdhury

Blood (2005) 106 (11): 4456.

https://doi.org/10.1182/blood.V106.11.4456.4456

Published: 2005

Journal Articles

Phase III Trial of All-Trans Retinoic Acid (ATRA) vs Daunorubicin (D) and Cytosine Arabinoside (A) as Induction Therapy and ATRA vs Observation as Maintenance Therapy for Children with Newly Diagnosed Acute Promyelocytic Leukemia (APL).

John Gregory, MD, Haesook Kim, PhD, Todd Alonzo, MD, Rob Gerbing, PhD, Angela Ogden, MD, William Woods, MD, Howard Weinstein, MD, Lois Shepherd, MD, Charles Schiffer, MD, Frederick Appelbaum, MD, Cheryl Willman, MD, Peter Wiernik, MD, Jacob Rowe, MD, Martin Tallman, MD, James Feusner, MD

Blood (2005) 106 (11): 894.

https://doi.org/10.1182/blood.V106.11.894.894

Published: 2005

Journal Articles

Mechanism of Selectivity of Arsenic Trioxide for Acute Promyelocytic Leukemia Cells from Screening a Genome Wide Set of Saccharomyces cerevisiae Deletion Strains.

Pierre J. Dilda, Gabriel G. Perrone, Ian W. Dawes, Philip J. Hogg

Blood (2005) 106 (11): 2470.

https://doi.org/10.1182/blood.V106.11.2470.2470

Published: 2005

Journal Articles

Histone Deacetylase Inhibitors and Filgrastim Do Not Synergize with ATRA in the Induction of Changes of Acute Promyelocytic Leukemia Cells Adhesive Properties.

Gil C. De Santis, Suzana E. Moreno, Hamilton L.G. Teixera, Ana Silvia G. Lima, Aglair B. Garcia, Roberto P. Falcao, Fernando Q. Cunha, Eduardo M. Rego

Blood (2004) 104 (11): 2548.

https://doi.org/10.1182/blood.V104.11.2548.2548

Published: 2004

Journal Articles

Decitabine-Induced Differentiation Syndrome in a Patient with Acute Myeloid Leukemia: A Case Report.

William Blum, M.D., Kristie A. Blum, M.D., Cheryl Kefauver, R.N., Mollie Moran, C.R.N.P., Kenneth Chan, Ph.D., John C. Byrd, M.D., Spero Cataland, M.D., Michael R. Grever, M.D., Guido Marcucci, M.D.

Blood (2004) 104 (11): 4528.

https://doi.org/10.1182/blood.V104.11.4528.4528

Published: 2004

Journal Articles

Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome: Presented in part at the meeting of the American Society of Hematology, San Diego, CA, December 1997.

Martin S. Tallman, Janet W. Andersen, Charles A. Schiffer, Frederick R. Appelbaum, James H. Feusner, Angela Ogden, Lois Shepherd, Jacob M. Rowe, Christopher François, Richard S. Larson, Peter H. Wiernik

Blood (2000) 95 (1): 90–95.

https://doi.org/10.1182/blood.V95.1.90

Published: 2000

Journal Articles

Retinoic Acid Induces Aggregation of the Acute Promyelocytic Leukemia Cell Line NB-4 by Utilization of LFA-1 and ICAM-2

Richard S. Larson, David C. Brown, Larry A. Sklar

Blood (1997) 90 (7): 2747–2756.

https://doi.org/10.1182/blood.V90.7.2747

Published: 1997

NARROW

Tamibarotene Compared to All-Trans Retinoic Acid (ATRA) As Add-on to Arsenic Trioxide (ATO) in Subjects with Relapsed Acute Promyelocytic Leukemia (APL)

Palladin Plays an Important Role in Pulmonary Cellular Infiltration in Differentiation Syndrome

How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia

Successful Pregnancy In APL Patients Treated According to the AIDA Protocol.

Chemokine Induction by All-Trans Retinoic Acid in Acute Promyelocytic Leukemia - Triggering the Retinoic Acid Syndrome

The Clinical Features and the Efficient Therapy of 66 Acute Promyelocytic Leukemia Patients with High Initial White Blood Cell Count.

Risk-Adapted Treatment of Acute Promyelocytic Leukemia: Updated Results of the Spanish PETHEMA LPA99 Trial Using ATRA and Anthracycline Monochemotherapy.

A Phase I Trial of Bexarotene, a Retinoid X Receptor Agonist, in non-M3 Acute Myeloid Leukemia: Evidence of Myeloid Differentiation and Clinical Activity.

A Novel and Efficient Induction Approach for Accelerated Differentiation and Rapid Hematopoietic Recovery in Acute Promyelocytic Leukemia (APL) Patients by Combining All-Trans Retinoic Acid (ATRA) with Granulocyte-Colony Stimulating Factor (G-CSF).

Increased Expression of Cyclin A1 mRNA Is a Novel Adverse Prognostic Indicator for Acute Promyelocytic Leukemia in Differentiation Therapy by All- Trans Retinoic Acid.

Retinoic Acid Syndrome in Patients with Acute Promyelocytic Leukemia Treated with All-Trans Retinoic Acid and Anthracycline Monochemotherapy.

Implications of RA-Induced CD38 Antigne in IFN gamma and IL-1 beta Induced Apoptosis of Endothelial Cells and Development of Retinoic Acid Syndrome.

Curcumin Enhances Differentiation of All- Trans Retinoic Acid (ATRA)-Sensitive and ATRA-Resistant Acute Promyelocytic (APL) Cells.

Phase III Trial of All-Trans Retinoic Acid (ATRA) vs Daunorubicin (D) and Cytosine Arabinoside (A) as Induction Therapy and ATRA vs Observation as Maintenance Therapy for Children with Newly Diagnosed Acute Promyelocytic Leukemia (APL).

Mechanism of Selectivity of Arsenic Trioxide for Acute Promyelocytic Leukemia Cells from Screening a Genome Wide Set of Saccharomyces cerevisiae Deletion Strains.

Histone Deacetylase Inhibitors and Filgrastim Do Not Synergize with ATRA in the Induction of Changes of Acute Promyelocytic Leukemia Cells Adhesive Properties.

Decitabine-Induced Differentiation Syndrome in a Patient with Acute Myeloid Leukemia: A Case Report.

Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome: Presented in part at the meeting of the American Society of Hematology, San Diego, CA, December 1997.

Retinoic Acid Induces Aggregation of the Acute Promyelocytic Leukemia Cell Line NB-4 by Utilization of LFA-1 and ICAM-2

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only